sexual
transmit
infect
reach
prostat
gland
harm
effect
mediat
innat
immun
includ
interferon
human
polymorph
germlin
dinucleotid
variant
gene
encod
interferon
sinc
allel
link
impair
viral
clearanc
hypothes
potenti
exposur
sexual
transmit
pathogen
assess
number
lifetim
sexual
partner
may
increas
prostat
cancer
risk
manner
accordingli
find
men
sexual
partner
least
one
copi
significantli
increas
risk
prostat
cancer
number
partner
lack
moreov
test
effect
modif
show
posit
interact
number
lifetim
partner
develop
aggress
prostat
cancer
base
find
conclud
geneenviron
interact
sexual
activ
may
increas
risk
prostat
cancer
sexual
transmit
infect
reach
prostat
gland
harm
effect
mediat
innat
immun
includ
interferon
human
polymorph
germlin
dinucleotid
variant
gene
encod
interferon
sinc
allel
link
impair
viral
clearanc
hypothes
potenti
exposur
sexual
transmit
pathogen
assess
number
lifetim
sexual
partner
may
increas
prostat
cancer
risk
manner
accordingli
find
men
sexual
partner
least
one
copi
significantli
increas
risk
prostat
cancer
number
partner
lack
moreov
test
effect
modif
show
posit
interact
number
lifetim
partner
develop
aggress
prostat
cancer
base
find
conclud
geneenviron
interact
sexual
activ
may
increas
risk
prostat
cancer
c
ancercaus
sexual
transmit
infect
sti
human
papillomaviru
hpv
human
immunodefici
viru
hiv
herp
simplex
viru
hsv
common
worldwid
hpv
infect
caus
cervic
head
neck
cancer
hiv
infect
caus
kaposi
sarcoma
prostat
gland
organ
easili
expos
infect
urogenit
tract
innat
immun
respons
urogenit
epithelium
provid
first
line
defens
pathogen
may
protect
urogenit
cancer
accordingli
studi
report
associ
prostat
cancer
risk
mutat
genet
variant
innat
immun
respons
gene
howev
evid
associ
sti
prostat
cancer
remain
inconclus
multipl
epidemiolog
studi
evalu
associ
lifetim
number
sexual
partner
proxi
sti
prostat
cancer
risk
report
posit
null
associ
therefor
hypothes
discord
observ
could
due
residu
confound
unknown
host
factor
modifi
relationship
sti
prostat
cancer
one
host
factor
import
innat
immun
respons
sti
could
germlin
dinucleotid
polymorph
tt
allel
gene
encod
typeiii
interferon
allel
creat
open
read
frame
thu
interferon
produc
carrier
allel
paradox
although
antivir
cytokin
potent
induc
jakstat
pathway
individu
carri
allel
impair
abil
clear
certain
viral
infect
hepat
c
viru
hcv
cytomegaloviru
coronaviru
possibl
hiv
effect
attribut
increas
induct
neg
regul
interferon
signal
could
affect
function
interferon
recent
show
close
associ
occurr
interferon
signatur
term
interferonrel
dna
damag
resist
signatur
ird
prostat
tumor
africanamerican
patient
decreas
overal
surviv
patient
group
thu
may
signific
function
prostat
cancer
biolog
present
studi
identifi
geneenviron
interact
increas
likelihood
exposur
sti
result
develop
aggress
prostat
cancer
suggest
yet
unidentifi
relationship
infecti
agent
prostat
cancer
men
clinic
demograph
characterist
particip
characterist
particip
ncimaryland
prostat
cancer
casecontrol
studi
previous
describ
studi
enrol
case
africanamerican
aa
europeanamerican
ea
popul
control
aa
ea
tabl
ask
sexual
histori
supplementari
tabl
case
control
similar
age
bmi
distribut
case
compar
control
first
degre
famili
histori
prostat
cancer
vs
p
chisquar
test
wherea
fewer
case
control
colleg
graduatelevel
degre
vs
p
chisquar
test
addit
case
current
smoker
control
vs
p
chisquar
test
among
case
men
advanc
diseas
stage
prostat
cancer
high
gleason
score
report
patient
aa
ea
men
similar
gleason
score
distribut
aa
men
tend
higher
blood
psa
level
diagnosi
greater
proport
ea
men
compar
aa
men
present
advanc
diseas
cohort
base
combin
lowhighgrad
localizedadvanc
diseas
see
method
case
assign
group
nonaggress
aggress
prostat
cancer
respect
number
sexual
partner
proxi
assess
exposur
sti
establish
valid
surrog
variabl
see
method
test
number
selfreport
sexual
partner
use
infer
exposur
gonorrhea
establish
sti
shown
supplementari
tabl
men
sexual
partner
teen
like
gonorrhea
infect
men
sexual
partner
men
partner
increas
odd
infect
relationship
statist
signific
analysi
men
combin
stratifi
control
case
lifetim
number
sexual
partner
also
correl
likelihood
contract
gonorrhea
exposuredepend
manner
supplementari
tabl
likelihood
contract
gonorrhea
increas
higher
lifetim
number
sexual
partner
p
trend
valid
util
proxi
variabl
infer
likelihood
exposur
sti
number
sexual
partner
prostat
cancer
risk
youngest
age
diagnosi
cohort
year
particip
prostat
cancer
diagnosi
therefor
could
report
sexual
partner
beyond
decid
look
exposur
teen
tabl
present
associ
sexual
activ
earli
adulthood
age
throughout
lifetim
prostat
cancer
observ
signific
associ
number
sexual
partner
men
teen
risk
develop
prostat
cancer
later
life
accord
multivari
model
although
trend
toward
increas
risk
observ
univari
analysi
hand
consid
number
sexual
partner
individu
individu
sexual
partner
increas
odd
prostat
cancer
respect
compar
men
partner
similarli
consid
total
number
sexual
partner
life
cours
men
sexual
partner
increas
odd
prostat
cancer
associ
signific
multivari
model
also
dosedepend
exampl
men
sexual
partner
risk
sexual
partner
p
trend
p
trend
find
indic
increas
exposur
sti
earli
adulthood
elev
individu
risk
develop
prostat
cancer
later
life
suggest
sti
may
play
role
etiolog
prostat
cancer
find
observ
ea
aa
men
howev
note
robust
risk
associ
among
aa
men
tabl
modifi
sexual
activityassoci
cancer
risk
genotyp
determin
case
control
avail
germlin
dna
expect
allel
common
among
aa
ea
men
supplementari
tabl
investig
whether
modifi
associ
likelihood
exposur
sti
prostat
cancer
risk
stratifi
particip
one
two
allel
vs
none
shown
fig
tabl
adjust
logist
regress
analysi
reveal
increas
risk
prostat
cancer
associ
sexual
activ
restrict
carrier
least
one
allel
instanc
among
individu
sexual
partner
odd
diagnosi
prostat
cancer
men
least
one
allel
vs
none
ci
vs
ci
respect
effect
allel
remain
statist
signific
adjust
race
ethnic
appli
bonferroniadjust
signific
threshold
p
reason
among
men
multipl
sexual
partner
earli
adulthood
carrier
two
copi
allel
genotyp
would
expect
higher
prostat
cancer
risk
one
copi
genotyp
increas
statist
power
test
hypothesi
combin
individu
moder
likelihood
exposur
sexual
partner
highest
likelihood
exposur
sexual
partner
compar
risk
refer
group
sexual
partner
shown
supplementari
tabl
among
increas
likelihood
exposur
sti
lifetim
odd
diagnosi
prostat
cancer
higher
carrier
tttt
genotyp
signific
relationship
number
sexual
partner
prostat
cancer
risk
among
tttt
carrier
howev
carrier
two
sexual
partner
sexual
partner
lifetim
increas
risk
instanc
men
two
sexual
partner
vs
none
odd
ratio
increas
examin
observ
test
statist
signific
interact
term
likelihood
exposur
sti
earli
adulthood
use
number
sexual
partner
surrog
measur
sti
likelihood
analysi
perform
prostat
cancer
case
stratifi
nonaggress
aggress
diseas
notabl
strongest
evid
geneenviron
interact
reveal
associ
interact
odd
develop
aggress
diseas
tabl
multipl
lifetim
sexual
partner
synergist
increas
odd
aggress
prostat
cancer
p
interact
associ
remain
signific
bonferroniadjust
signific
threshold
p
appli
made
similar
observ
examin
associ
aa
africanamerican
ea
europeanamerican
iqr
interquartil
rang
sd
standard
deviat
psa
prostat
specif
antigen
case
recruit
within
year
diseas
diagnosi
averag
interv
diagnosi
enrol
month
b
age
studi
interview
c
firstdegre
rel
prostat
cancer
smoke
statu
describ
cigarett
smoke
e
patholog
confirm
use
american
joint
committe
cancer
ajcc
edit
f
case
patholog
confirm
gleason
score
g
case
patholog
confirm
gleason
score
number
sexual
partner
diseas
risk
among
carrier
strata
aggress
nonaggress
prostat
cancer
shown
fig
tabl
carrier
sexual
partner
lifetim
partner
tend
higher
odd
diagnos
aggress
nonaggress
diseas
diverg
allel
frequenc
across
popul
asian
european
african
lead
wide
rang
popul
attribut
risk
associ
genet
variant
given
allel
frequenc
higher
aa
stratifi
analysi
raceethn
found
odd
diagnos
aggress
prostat
cancer
men
sexual
partner
lifetim
partner
higher
among
aa
men
ea
men
tabl
consist
increas
frequenc
risk
allel
aa
compar
racial
group
aa
men
multipl
sexual
partner
increas
odd
diagnosi
aggress
prostat
cancer
vs
nonaggress
prostat
cancer
tabl
similarli
men
least
one
copi
allel
multipl
sexual
partner
associ
increas
odd
diagnosi
aggress
prostat
cancer
vs
nonaggress
prostat
cancer
tabl
ea
men
howev
relationship
either
nonsignific
borderlin
signific
suggest
higher
preval
allel
aa
men
could
contribut
increas
risk
aggress
prostat
cancer
exact
viral
pathogen
caus
sti
prostat
gland
unknown
infect
human
prostat
cancer
cell
line
sendai
viru
sev
murin
rna
viru
infect
divers
human
cell
type
induc
robust
antivir
respons
includ
express
primari
human
hepatocyt
sevinfect
human
prostat
cancer
cell
line
observ
robust
induct
transcript
region
supplementari
figur
supplementari
tabl
note
mrna
induct
allelespecif
detect
cell
tttt
genotyp
although
express
gener
lower
tttt
genotyp
due
nonsensemedi
decay
prematur
termin
outoffram
transcript
howev
protein
produc
presenc
allel
inde
western
blot
analysi
show
strongli
induc
sevinfect
cell
genotyp
cell
tttt
genotyp
fig
supplementari
figur
key
find
studi
reveal
geneenviron
interact
prostat
cancer
etiolog
increas
exposur
sti
due
sexual
activ
germlin
genet
variant
regul
innat
immun
respons
infect
epitheli
cell
observ
consist
across
age
group
genotyp
strata
furthermor
odd
develop
prostat
cancer
particularli
aggress
type
increas
number
sexual
partner
men
carri
allel
aa
like
ea
men
carri
allel
effect
pronounc
former
popul
identif
novel
geneenviron
interact
suggest
associ
yet
unidentifi
infecti
agent
prostat
cancer
risk
men
effort
warrant
identifi
etiolog
agent
odd
ratio
ci
confid
interv
uncondit
logist
regress
adjust
bodi
mass
index
studi
enrol
bmi
kg
age
studi
entri
educ
high
school
less
colleg
colleg
profession
school
famili
histori
prostat
cancer
first
degre
rel
yesno
smoke
histori
never
former
current
condom
use
usual
use
yesno
aspirin
use
regular
user
yesno
genotyp
vs
tttt
race
b
uncondit
logist
regress
adjust
bodi
mass
index
studi
enrol
bmi
kg
age
studi
entri
educ
high
school
less
colleg
colleg
profession
school
famili
histori
prostat
cancer
first
degre
rel
yesno
smoke
histori
never
former
current
condom
use
usual
use
yesno
aspirin
use
regular
user
yesno
genotyp
vs
tttt
bold
data
indic
signific
associ
multivari
logist
regress
analysi
c
bonferronicorrect
signific
threshold
multipl
comparison
total
n
stratifi
n
analys
respect
sinc
first
document
implic
sti
possibl
etiolog
agent
prostat
cancer
earli
multipl
epidemiolog
studi
subsequ
explor
relationship
yet
epidemiolog
evid
associ
sti
prostat
cancer
still
firmli
establish
multipl
studi
selfreport
exposur
sti
common
symptomat
sti
ie
gonorrhea
report
posit
associ
resembl
epidemiolog
literatur
cervic
cancer
discoveri
hpv
etiolog
agent
studi
observ
selfreport
exposur
gonorrhea
increas
odd
diagnosi
prostat
cancer
supplementari
tabl
concord
metaanalysi
data
report
increas
risk
respect
search
prostat
cancer
etiolog
agent
also
encompass
seroepidemiolog
evalu
associ
prostat
cancer
risk
infect
human
herpesviru
herp
simplex
type
hpv
chlamydia
trachomati
trichomona
vaginali
report
find
far
conclus
although
observ
geneenviron
interact
relat
sti
implic
specif
sti
suggest
exposur
sexual
transmit
etiolog
agent
may
lead
prostat
cancer
genet
suscept
individu
ncimaryland
casecontrol
studi
observ
men
multipl
sexual
partner
henc
may
increas
likelihood
exposur
sti
earli
adulthood
higher
odd
diagnosi
aggress
prostat
cancer
later
life
consist
increas
preval
allel
among
individu
african
ancestri
associ
stronger
aa
ea
men
vitro
infect
prostat
cancer
cell
line
sev
model
wide
rang
rna
virus
show
induct
cell
line
homozygot
allel
cell
line
without
allel
support
hypothesi
viral
origin
express
prostat
tissu
detect
induct
endogen
protein
shown
hepat
cell
induc
protein
may
enhanc
neg
regul
ifn
signal
lead
impair
viral
clearanc
distinct
tumor
biolog
carrier
allel
previous
report
impair
ifn
signal
may
also
affect
innat
immun
respons
nonvir
pathogen
common
individu
african
ancestri
compar
european
ancestri
observ
compar
distribut
casecontrol
studi
allel
frequenc
among
aa
ea
men
respect
supplementari
tabl
line
health
dispar
prostat
cancer
manifest
aggress
deadli
diseas
aa
compar
racial
group
moreov
find
studi
also
consist
previou
work
observ
distinct
interferon
signatur
preval
tumor
aa
ea
men
role
interferoninduc
system
pathogenesi
aggress
form
prostat
cancer
suggest
germlin
mutat
rnasel
gene
involv
interferon
antivir
pathway
found
predispos
men
famili
prostat
cancer
carrier
allel
multipl
sexual
partner
earli
adulthood
increas
odd
diagnos
aggress
prostat
cancer
later
life
contrari
men
variant
bear
similar
stiassoci
prostat
cancer
risk
even
mani
partner
howev
may
predispos
prostat
cancer
context
sti
exampl
shown
herpesviru
infect
latenc
confer
protect
bacteri
infect
thu
chronic
viral
infect
carrier
may
lead
decreas
risk
bacteri
infect
accordingli
found
associ
gonorrhea
prostat
cancer
stronger
carrier
supplementari
tabl
argu
overal
unfavor
associ
prostat
cancer
shown
studi
like
relat
infecti
agent
viral
origin
addit
studi
need
identifi
microbi
agent
studi
sever
limit
consid
gener
casecontrol
studi
design
influenc
inher
bias
includ
recal
respons
interview
bias
studi
affect
interview
bia
sinc
sexual
histori
inform
acquir
selfadminist
questionnair
fill
privaci
howev
reli
retrospect
selfreport
assess
sexual
histori
vulner
recal
bia
view
unlik
gener
popul
awar
infecti
hypothesi
context
prostat
cancer
argu
recal
bia
addit
fact
selfreport
number
sexual
partner
could
use
infer
exposur
gonorrhea
case
control
similar
manner
suggest
casecontrol
statu
p
valu
departur
addit
interact
base
likelihood
ratio
test
model
without
interact
term
analys
adjust
bodi
mass
index
studi
enrol
bmi
kg
age
studi
entri
educ
high
school
less
colleg
colleg
profession
school
famili
histori
prostat
cancer
first
degre
rel
yesno
smoke
histori
never
former
current
condom
use
usual
use
yesno
aspirin
use
regular
user
yesno
race
bold
data
indic
statist
evid
synergi
bonferronicorrect
signific
threshold
multipl
comparison
total
n
stratifi
n
analys
respect
influenc
selfreport
sexual
histori
supplementari
tabl
likewis
fact
observ
stiassoci
prostat
cancer
risk
exclus
men
least
one
copi
allel
wherea
men
tttt
genotyp
albeit
group
report
multipl
sexual
partner
make
rather
unlik
recal
bia
contribut
find
report
associ
diseas
risk
context
sexual
activ
could
confoundingbia
observ
odd
ratio
ci
confid
interv
uncondit
logist
regress
adjust
bodi
mass
index
studi
enrol
bmi
kg
age
studi
entri
educ
high
school
less
colleg
colleg
profession
school
famili
histori
prostat
cancer
first
degre
rel
yesno
smoke
histori
never
former
current
condom
use
usual
use
yesno
aspirin
use
regular
user
yesno
race
bold
data
indic
signific
associ
multivari
logist
regress
analysi
b
bonferronicorrect
signific
threshold
multipl
comparison
n
men
knew
genotyp
certainli
report
sexual
activ
bias
knowledg
buttress
valid
observ
also
found
signific
relationship
gonorrhea
infect
histori
prostat
cancer
consist
manner
recent
metaanalys
yet
remain
limit
could
valid
find
second
cohort
studi
popul
rather
uniqu
aa
subject
indepth
survey
sexual
activ
germlin
dna
genotyp
make
difficult
replic
find
without
requir
addit
recruit
nevertheless
fact
observ
dose
respons
relationship
fit
biolog
plausibl
mechan
suggest
associ
observ
warrant
investig
includ
prospect
cohort
conclus
increas
likelihood
exposur
sti
among
men
genet
impair
clearanc
viral
infect
found
posit
associ
risk
prostat
cancer
although
find
implic
specif
sti
strongli
argu
infect
etiolog
agent
prostat
cancer
substanti
subset
patient
whether
observ
associ
due
carcinogen
effect
put
etiolog
infecti
agent
rather
due
host
respons
infecti
agent
need
examin
futur
work
data
suggest
etiolog
prostat
cancer
may
vari
popul
group
due
ancestryrel
genet
variat
resolut
progress
infect
follow
exposur
propos
synergist
mechan
prostat
cancer
pathophysiolog
relev
popul
could
disproport
affect
men
african
ancestri
find
may
shed
light
prostat
cancer
health
dispar
method
ncimaryland
prostat
cancer
casecontrol
studi
casecontrol
studi
previous
describ
studi
initi
test
primari
hypothesi
environment
exposur
ancestryrel
factor
contribut
excess
prostat
cancer
burden
among
aa
men
briefli
prior
interview
subject
sign
inform
consent
particip
studi
form
procedur
approv
nci
protocol
univers
maryland
protocol
institut
review
board
case
recruit
baltimor
veteran
affair
medic
center
univers
maryland
medic
center
elig
criteria
includ
follow
diagnosi
prostat
cancer
within
two
year
prior
enrol
resid
maryland
adjac
counti
pennsylvania
delawar
virginia
district
columbia
year
old
time
enrol
born
unit
state
either
africanamerican
aa
europeanamerican
ea
selfreport
interview
english
work
home
phone
number
physic
mental
fit
interview
sever
ill
resid
institut
prison
nurs
home
shelter
total
case
aa
ea
men
recruit
studi
control
identifi
maryland
depart
motor
vehicl
administr
databas
frequencymatch
case
age
race
control
also
elig
criteria
case
except
could
person
histori
cancer
nonmelanoma
skin
cancer
radiat
therapi
chemotherapi
total
popul
control
recruit
aa
ea
men
time
enrol
case
control
administ
survey
train
interview
blood
sampl
mouthwash
rinsebucc
cell
collect
survey
ask
demograph
tobacco
use
nutrit
medic
histori
famili
histori
cancer
prostat
benign
prostat
hypertrophi
occup
histori
socioeconom
statu
anthropometri
sexual
histori
particip
given
min
privaci
complet
sexual
histori
section
survey
assess
sexual
histori
sexual
histori
section
survey
assess
particip
number
sexual
partner
use
follow
question
throughout
life
total
number
partner
sexual
intercoursefew
teen
mani
differ
partner
particip
case
control
report
number
sexual
partner
teen
throughout
life
respect
remaind
either
declin
answer
provid
incomplet
inform
supplementari
tabl
lifetim
number
sexual
partner
categori
collaps
new
categori
wherea
categori
collaps
togeth
new
categori
similarli
number
sexual
partner
men
differ
age
decad
teen
collaps
categori
three
group
refer
group
sexual
partner
presum
low
chanc
contract
sti
medium
risk
group
sexual
partner
intermedi
likelihood
contract
sti
higher
risk
group
sexual
partner
highest
likelihood
contract
sti
sexual
histori
section
also
ask
histori
condom
use
use
follow
question
usual
use
condom
rubber
ye
assess
histori
sexual
transmit
diseas
medic
histori
section
questionnair
ask
particip
histori
two
sexual
transmit
diseas
use
follow
question
doctor
ever
tell
gonorrheano
ye
doctor
ever
tell
syphilisno
ye
particip
answer
ye
either
two
question
ask
followup
question
old
first
diagnos
mani
time
altogeth
diseas
histori
syphili
infect
analyz
detail
report
particip
case
control
infect
gonorrhea
common
case
control
inform
use
analysi
prostat
cancer
classif
gleason
grade
system
use
classifi
prostat
tumor
lowgrad
gleason
score
highgrad
gleason
score
tumor
stage
diagnosi
obtain
medic
record
stage
defin
local
stage
advanc
diseas
case
combin
lowgrad
tumor
local
diseas
defin
nonaggress
prostat
cancer
case
either
highgrad
tumor
advanc
diseas
defin
aggress
prostat
cancer
genotyp
genom
dna
isol
buffi
coat
avail
cell
line
use
dneasi
blood
tissu
kit
qiagen
subset
men
case
control
genom
dna
obtain
mouthwash
sampl
use
gentra
puregen
buccal
cell
kit
qiagen
total
genom
dna
avail
case
studi
particip
control
genotyp
done
previous
describ
customdesign
assay
purchas
thermo
fisher
genotyp
perform
use
abi
appli
biosystem
accord
standard
protocol
genotyp
concord
among
duplic
deviat
hardyweinberg
equilibrium
control
genotyp
success
rate
genotyp
failur
rate
similar
dna
extract
blood
mouthwash
sampl
genotyp
along
clinic
inform
case
control
present
supplementari
data
sev
infect
express
analysi
human
prostat
cancer
cell
line
genotyp
tttt
genotyp
obtain
american
type
cultur
collect
manassa
va
cell
regularli
authent
use
short
tandem
repeat
analysi
test
mycoplasma
contamin
cell
line
supplementari
fig
commonli
misidentifi
per
regist
misidentifi
cell
line
curat
iclac
intern
cell
line
authent
committe
cell
cultur
medium
atcc
manassa
va
fb
cultur
eagl
minimum
essenti
medium
atcc
fb
sev
infect
done
describ
protein
express
analysi
cell
seed
overnight
densiti
cell
sixwel
plate
infect
triplic
sev
cantel
strain
charl
river
laboratori
mock
control
h
harvest
lyse
ripa
sigma
supplement
proteas
inhibitor
promega
puls
sonic
burstcool
cycl
lysat
centrifug
g
min
supernat
boil
reduc
sampl
buffer
min
resolv
bistri
bolt
gel
transfer
use
iblot
thermo
fisher
blot
block
milk
h
incub
rabbit
abcam
develop
secondari
hrplink
goat
antirabbit
antibodi
cell
signal
technolog
supersign
west
femto
maximum
sensit
substrat
thermo
fisher
gene
express
cell
infect
sev
describ
h
total
rna
extract
use
rneasi
kit
oncolumn
dnase
digest
qiagen
cdna
gener
ng
total
rna
first
strand
kit
qiagen
addit
dna
remov
step
total
rna
input
ng
per
reaction
express
measur
technic
quadruplicatesof
endogen
control
gapdh
actb
use
taqman
express
assay
sev
load
measur
sybr
green
express
assay
sev
defectiveinterf
rna
previous
describ
quantstudio
thermo
fisher
use
express
analysi
statist
analysi
statist
analys
perform
use
statas
statist
softwar
packag
stata
corp
statist
test
twosid
p
consid
statist
signific
use
bonferroni
method
multipl
comparison
correct
base
number
survey
question
main
analys
n
addit
subgroup
stratifi
analys
bonferroniadjust
signific
threshold
report
footnot
tabl
main
analysi
evalu
whether
sexual
histori
variabl
associ
prostat
cancer
stratifi
race
ethnic
aa
vs
ea
vs
tttt
case
case
aggress
vs
nonaggress
diseas
uncondit
logist
regress
use
comput
odd
ratio
confid
interv
ci
assess
associ
sexual
histori
medic
histori
paramet
number
sexual
partner
differ
age
decad
total
number
sexual
partner
histori
gonorrhea
prostat
cancer
adjust
potenti
confound
factor
bodi
mass
index
studi
enrol
bmi
kg
age
enrol
educ
high
school
less
colleg
colleg
profession
school
famili
histori
prostat
cancer
first
degre
rel
yesno
smoke
histori
never
former
current
condom
use
usual
use
yesno
aspirin
use
regular
user
yesno
vs
tttt
raceethn
applic
test
geneenviron
interact
number
sexual
partner
proxi
likelihood
exposur
sti
examin
departur
addit
appli
multivari
model
without
interact
term
examin
signific
likelihood
ratio
test
result
adjust
potenti
confound
factor
list
p
consid
statist
evid
effect
modif
